Effect of Interval and Resistance Exercise on Physiological and Psychological Parameters.

The purpose of this study is to examine the physiological and psychological effects of a sprint interval and resistance training intervention on females.

Study Overview

• Status: Completed
• Conditions: Body Composition
• Intervention / Treatment: Behavioral: SIT and resistance training

Detailed Description

Females aged 20-65 will attend 10 weeks of exercise training consisting of sprint interval training and resistance training for 30 sessions. We will examine changes in body composition, blood panel (fasting glucose, cholesterol, triglycerides), strength (bench press and back squat), aerobic capacity and psychological parameters (hardiness, affect, enjoyment, perception and self-regulation). The effects will be measured acutely after the program and 6-months after the cessation of the program.

• Study Type: Interventional
• Enrollment (Actual): 42
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Alabama
    • Auburn, Alabama, United States, 36830
      • School of Kinesiology

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 25 years to 55 years (ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• This population consists of: females, aged 25-55, who are: sedentary (not reporting a regular schedule of exercise over the last 3 months), and able to start an exercise program (assessed by the PARQ+)

Exclusion Criteria:

• Females who are below age 25 or over age 55, who are currently exercising and have existing conditions that would exclude them from exercise.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: NA
• Interventional Model: SINGLE_GROUP
• Masking: NONE

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: SIT and Resistance; Participants will complete 10 weeks of a SIT and resistance training paradigm.	Behavioral: SIT and resistance training; Participants complete 30 sessions of sprints and resistance training. Outcomes are assessed acutely and at 6 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fat mass post	Changes in Fat mass in Kg assessed by idexa	Change in fat mass at 13 weeks
Fat mass retention	Changes in Fat mass in Kg assessed by idexa	Change in fat mass at 6 months
Lean mass post	Changes in Lean mass in Kg assessed by idexa	Change in lean mass at 13 weeks
Lean mass retention	Changes in Lean mass in Kg assessed by idexa	Change in lean mass at 6 months
Visceral Fat post	Changes in Visceral Fat in Kg assessed by idexa	Change in visceral fat at 13 weeks
Visceral Fat retention	Changes in Visceral Fat in Kg assessed by idexa	Change in visceral fat at 13 weeks
Participate perception of the program post	Interviews to assess participants perception of the program	13 weeks
Participate perception of the program retention	Interviews to assess participants perception of the program	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Strength - bench press	Changes in bench press measured in Kg	Change in bench press at 13 weeks
Strength - back squat	Changes in back squat measured in Kg	Change in back squat at 13 weeks
Blood glucose post	Changes in fasting blood glucose	Changes in fasting blood glucose at 13 weeks
Blood glucose retention	Changes in fasting blood glucose	Changes in fasting blood glucose at 6 months
Cholesterol post	Changes in Cholesterol	Changes in Cholesterol at 13 weeks
Cholesterol retention	Changes in Cholesterol	Changes in Cholesterol at 6 months
Triglycerides post	Changes in Triglycerides	Changes in Triglycerides at13 weeks
Triglycerides retention	Changes in Triglycerides	Changes in Triglycerides at 6 months

Collaborators and Investigators

• Sponsor: Auburn University
• Investigators: Principal Investigator: Danielle Wadsworth, PhD, Auburn University

Study record dates

Study Major Dates

• Study Start (ACTUAL): January 20, 2019
• Primary Completion (ACTUAL): December 31, 2020
• Study Completion (ACTUAL): December 31, 2020

Study Registration Dates

• First Submitted: February 7, 2021
• First Submitted That Met QC Criteria: February 10, 2021
• First Posted (ACTUAL): February 12, 2021

Study Record Updates

• Last Update Posted (ACTUAL): February 12, 2021
• Last Update Submitted That Met QC Criteria: February 10, 2021
• Last Verified: February 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: 18-323

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: No IPD will be shard with other researchers.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No